MedPath
TGA Approval

MOUNJARO tirzepatide 2.5 mg/0.5 mL solution for injection pre-filled pen (382625)

382625

MOUNJARO tirzepatide 2.5 mg/0.5 mL solution for injection pre-filled pen

Eli Lilly Australia Pty Ltd

December 23, 2022

Medicine

Medicine

Active

Registered

Active Ingredients

tirzepatide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.